These data, together with our findings, indicate that mutations in PIK3R1 and PTEN or KRAS may work together for efficient transformation into endometrioid ovarian cancer that may represent type I tumors in ovarian cancer classification. This evidence concerns the gene KRAS and ovarian carcinoma.